GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $30,461,000 | -25.6% | 953,396 | -19.4% | 6.97% | -28.0% |
Q1 2022 | $40,955,000 | +88.3% | 1,182,307 | +59.1% | 9.68% | +35.1% |
Q4 2021 | $21,748,000 | +241.4% | 743,000 | +197.2% | 7.17% | +209.6% |
Q3 2021 | $6,370,000 | -13.4% | 250,000 | +19.0% | 2.32% | -23.4% |
Q2 2021 | $7,354,000 | +3.1% | 210,000 | +20.0% | 3.02% | +0.6% |
Q1 2021 | $7,131,000 | -23.4% | 175,000 | -18.6% | 3.01% | -9.7% |
Q4 2020 | $9,312,000 | – | 215,000 | – | 3.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
Grace Capital | 312,514 | $11,876,000 | 4.65% |
NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |